Dongxia Gao

Dongxia Gao

UNVERIFIED PROFILE

Are you Dongxia Gao?   Register this Author

Register author
Dongxia Gao

Dongxia Gao

Publications by authors named "Dongxia Gao"

Are you Dongxia Gao?   Register this Author

35Publications

1315Reads

47Profile Views

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Mod Pathol 2019 Dec 1;32(12):1772-1785. Epub 2019 Jul 1.

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0312-yDOI Listing
December 2019

Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).

J Natl Cancer Inst 2019 Oct 30. Epub 2019 Oct 30.

Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz213DOI Listing
October 2019

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.

Breast Cancer Res Treat 2019 Sep 14. Epub 2019 Sep 14.

Genetic Pathology Evaluation Centre and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05438-yDOI Listing
September 2019

Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.

Int J Cancer 2019 05 6;144(10):2578-2586. Epub 2018 Dec 6.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.31969
Publisher Site
http://dx.doi.org/10.1002/ijc.31969DOI Listing
May 2019

TIM-3 expression in breast cancer.

Oncoimmunology 2018 23;7(11):e1502128. Epub 2018 Aug 23.

Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2018.1502128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205019PMC
August 2018

Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.

Breast Cancer Res Treat 2018 Feb 20;168(1):107-115. Epub 2017 Nov 20.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, 509-2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4583-z
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4583-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823734PMC
February 2018

Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.

Histopathology 2017 Jan 29;70(2):185-194. Epub 2016 Sep 29.

Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13038DOI Listing
January 2017

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.

Breast Cancer Res Treat 2016 Feb 4;155(3):483-90. Epub 2016 Feb 4.

Department of Laboratory Medicine and Pathology, University of British Columbia, 899 W 12th Ave, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3689-zDOI Listing
February 2016

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.

Cell Metab 2015 Oct 10;22(4):577-89. Epub 2015 Sep 10.

Goodman Cancer Research Centre, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H3A 1A3, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2015.08.007DOI Listing
October 2015

An international Ki67 reproducibility study.

J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.

Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888090PMC
December 2013

A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.

Mod Pathol 2013 Nov 24;26(11):1438-50. Epub 2013 May 24.

1] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada [2] Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.97DOI Listing
November 2013

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.

Breast Cancer Res 2012 Mar 15;14(2):R48. Epub 2012 Mar 15.

Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC, V6H 3Z6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446382PMC
March 2012

Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.

Breast Cancer Res Treat 2012 Feb 15;132(1):131-42. Epub 2011 May 15.

Division of Medical Oncology, BC Cancer Agency, Cancer Agency, 600 W 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1529-8DOI Listing
February 2012

Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.

Sarcoma 2010 13;2010:174528. Epub 2010 Oct 13.

Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada V5Z 1M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/174528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957133PMC
July 2011

Biomarker expression in pelvic high-grade serous carcinoma: comparison of ovarian and omental sites.

Int J Gynecol Pathol 2011 Jul;30(4):366-71

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e31820d20baDOI Listing
July 2011

Calculator for ovarian carcinoma subtype prediction.

Mod Pathol 2011 Apr 3;24(4):512-21. Epub 2010 Dec 3.

Genetic Pathology Evaluation Centre, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.215DOI Listing
April 2011

The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.

J Pathol 2010 Oct;222(2):191-8

Department of Pathology and Laboratory Medicine, Calgary Laboratory Services/Alberta Health Services and University of Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2744DOI Listing
October 2010

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

J Natl Cancer Inst 2009 May 12;101(10):736-50. Epub 2009 May 12.

Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/djp082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684553PMC
May 2009

Significance of HER-2/neu expression in ovarian epithelial tumours.

Zhonghua Bing Li Xue Za Zhi 2002 Jun;31(3):268-70

Department of pathology, Health Science Center of Peking University, Beijing, 100083, China (Email:

View Article

Download full-text PDF

Source
June 2002